Verdence Capital Advisors LLC Purchases Shares of 2,962 Astera Labs, Inc. $ALAB

Key Points

• Verdence Capital Advisors LLC has acquired 2,962 shares of Astera Labs, valued at approximately $268,000, indicating growing institutional interest in the company.
• Astera Labs reported $0.44 earnings per share (EPS) for the last quarter, surpassing analyst estimates of $0.33, and achieved a year-over-year revenue increase of 149.5%.
• Several analysts have set new price targets for Astera Labs, with Citigroup raising its target from $160.00 to $275.00, while the current consensus rating for the stock is a "Moderate Buy."

Verdence Capital Advisors LLC purchased a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 2,962 shares of the company's stock, valued at approximately $268,000.

A number of other large investors have also recently bought and sold shares of ALAB. Farther Finance Advisors LLC boosted its position in Astera Labs by 198.6% in the first quarter. Farther Finance Advisors LLC now owns 1,284 shares of the company's stock valued at $80,000 after buying an additional 854 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Astera Labs by 55.7% in the 1st quarter. GAMMA Investing LLC now owns 794 shares of the company's stock valued at $47,000 after acquiring an additional 284 shares during the last quarter. Envestnet Portfolio Solutions Inc. boosted its holdings in shares of Astera Labs by 9.4% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 4,946 shares of the company's stock valued at $295,000 after acquiring an additional 426 shares during the last quarter. Cherry Creek Investment Advisors Inc. boosted its holdings in shares of Astera Labs by 17.7% in the 1st quarter. Cherry Creek Investment Advisors Inc. now owns 3,547 shares of the company's stock valued at $212,000 after acquiring an additional 534 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. boosted its holdings in Astera Labs by 63.8% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 13,906 shares of the company's stock valued at $830,000 after purchasing an additional 5,416 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company's stock.

Astera Labs Trading Up 1.3%

Shares of ALAB stock opened at $163.55 on Friday. The company has a market capitalization of $27.19 billion, a P/E ratio of 292.05, a P/E/G ratio of 4.02 and a beta of 1.43. The business's 50 day moving average is $200.07 and its two-hundred day moving average is $127.18. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. During the same quarter last year, the firm posted $0.13 EPS. The business's revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, research analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have commented on ALAB shares. TD Cowen started coverage on shares of Astera Labs in a report on Wednesday, October 1st. They issued a "hold" rating and a $200.00 price target on the stock. Citigroup upped their target price on Astera Labs from $160.00 to $275.00 and gave the stock a "buy" rating in a research note on Wednesday, September 17th. Northland Securities downgraded Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 target price on the stock. in a research note on Tuesday, July 22nd. Needham & Company LLC upped their price objective on Astera Labs from $100.00 to $170.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Finally, Bank of America began coverage on Astera Labs in a research report on Friday, October 3rd. They issued a "neutral" rating and a $230.00 price objective on the stock. Fifteen investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $159.83.

Insider Buying and Selling at Astera Labs

In related news, Director Manuel Alba sold 183,000 shares of the firm's stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total value of $31,708,410.00. Following the transaction, the director directly owned 385,863 shares of the company's stock, valued at approximately $66,858,482.01. This trade represents a 32.17% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Sanjay Gajendra sold 280,000 shares of the firm's stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the completion of the transaction, the chief operating officer directly owned 5,525,545 shares in the company, valued at $939,453,160.90. This represents a 4.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,182,514 shares of company stock valued at $202,298,671. Insiders own 12.50% of the company's stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.